First Eagle Investment's DGX Position Overview
First Eagle Investment (via First Eagle Investment Management, LLC) currently holds 3,000 shares of Quest Diagnostics Incorporated (DGX) worth $587,940, representing 0.00% of the portfolio. First purchased in 2022-Q1, this medium-term investment has been held for 17 quarters.
Based on 13F filings, First Eagle Investment has maintained a strategic position in DGX, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2023, adding 3,397 shares. Largest reduction occurred in Q3 2025, reducing 1,862 shares.
Analysis based on 13F filings available since 2013 Q2
First Eagle Investment's Quest Diagnostics Incorporated (DGX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Quest Diagnostics Incorporated (DGX) Trades by First Eagle Investment
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -935 | Reduce 23.76% | 3,000 | $195.98 |
| Q4 2025 | +100 | Add 2.61% | 3,935 | $173.53 |
| Q3 2025 | -1,862 | Reduce 32.68% | 3,835 | $190.58 |
| Q2 2025 | +148 | Add 2.67% | 5,697 | $179.63 |
| Q1 2025 | +600 | Add 12.12% | 5,549 | $169.20 |
| Q3 2024 | +500 | Add 11.24% | 4,949 | $155.25 |
| Q2 2024 | +600 | Add 15.59% | 4,449 | $136.88 |
| Q3 2023 | +178 | Add 4.85% | 3,849 | $121.86 |
| Q1 2023 | +3,397 | Add 1239.78% | 3,671 | $141.48 |
| Q4 2022 | -25 | Reduce 8.36% | 274 | $156.44 |
| Q3 2022 | +168 | Add 128.24% | 299 | $123.75 |
| Q1 2022 | +131 | New Buy | 131 | $137.40 |
First Eagle Investment's Quest Diagnostics Incorporated Investment FAQs
First Eagle Investment first purchased Quest Diagnostics Incorporated (DGX) in Q1 2022, acquiring 131 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
First Eagle Investment has held Quest Diagnostics Incorporated (DGX) for 17 quarters since Q1 2022.
First Eagle Investment's largest addition to Quest Diagnostics Incorporated (DGX) was in Q1 2023, adding 3,671 shares worth $519,373.
According to the latest 13F filing for Q1 2026, First Eagle Investment's firm, First Eagle Investment Management, LLC, owns 3,000 shares of Quest Diagnostics Incorporated (DGX), valued at approximately $587,940.
As of the Q1 2026 filing, Quest Diagnostics Incorporated (DGX) represents approximately 0.00% of First Eagle Investment's publicly disclosed stock portfolio, making it one of their key holdings.
First Eagle Investment's peak holding in Quest Diagnostics Incorporated (DGX) was 5,697 shares, as reported at the end of Q2 2025.